![Melissa K. Carpenter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Melissa K. Carpenter
Directeur/Membre du Conseil chez
The International Society for Stem Cell Research
Profil
Dr. Melissa K.
Carpenter is an Associate at Proteus Venture Partners LLC (Venture Capital).
Dr. Carpenter was previously employed as Vice President-Research & Development by ViaCyte, Inc. She was also employed at CytoTherapuetics, Inc. and served on the board at Geron Corp.
and CyThera, Inc.
Dr. Carpenter received her PhD in Laboratory of Cellular and Molecular Neurobiology from the University of California, Irvine.
Postes actifs de Melissa K. Carpenter
| Sociétés | Poste | Début |
|---|---|---|
The International Society for Stem Cell Research
 The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content. | Directeur/Membre du Conseil | 18/03/2021 |
Anciens postes connus de Melissa K. Carpenter
| Sociétés | Poste | Fin |
|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM invests in companies located in the United States. The firm focuses on regenerative medicine, cell therapy, gene therapy, tissue engineering, bio-asethic medicine and underpinning technologies sectors. It provides financing for early stage capital requirements. | Private Equity Investor | - |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Corporate Officer/Principal | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cell replacement therapies for treating human degenerative diseases | Corporate Officer/Principal | - |
| GERON CORPORATION | Corporate Officer/Principal | - |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Melissa K. Carpenter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops cell replacement therapies for treating human degenerative diseases | Commercial Services |
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The International Society for Stem Cell Research
The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content. | |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM invests in companies located in the United States. The firm focuses on regenerative medicine, cell therapy, gene therapy, tissue engineering, bio-asethic medicine and underpinning technologies sectors. It provides financing for early stage capital requirements. | Finance |
